Browsing Category
Investments
From Hundreds Of CBD Suppliers To A Dozen – Potential Impact Of UK Regulator’s Novel Food Move
There are thousands of CBD brands in the U.K. and Europe, and tens of thousands of products. These brands and their while-label wholesalers are served by hundreds of global suppliers varying in size from small family farms to large…
Read More...
Read More...
Surprise U-Turn Sees U.K. Regulators Question Safety Of CBD
BRITISH authorities have expressed concerns over the safety of CBD in moves which could harm the booming industry. Click here for an update on this topic. These emerged in a report in The Times newspaper which highlighted Food Standards…
Read More...
Read More...
Former New York Knick Al Harrington Tells Ex-Players to Be Patient With Cannabis Sector
Despite the sector’s volatile state after a roller coaster 2019, former National Basketball Association forward Al Harrington continues to steer his fellow athletes to invest in cannabis while remaining patient on investment returns. “What…
Read More...
Read More...
Mixed Industry Reaction To U.K. Regulator’s CBD Crackdown
THE FSA’s plans to regulate CBD as a Novel Food and cautions over its potentially harmful health effects have prompted a mixed reaction in the industry. Most businesses have welcomed the clarity it will provide, highlighting the…
Read More...
Read More...
Can ‘Divine Intervention’ Help Save The CBD Industry In Europe?
The favoured dish of a medieval Pope may help free the CBD industry in Europe from its regulatory limbo. Last year’s European Commission (E.C.) designation of CBD as a Novel Food rocked the fast-growing industry. Leading the fight…
Read More...
Read More...
Only A ‘Dozen’ Domestic Canadian LP Facilities Have Secured EU-GMP Compliance
The European medical cannabis market is a tough nut to crack for Canadian cannabis firms who face a more stringent regulatory regime than at home. Aphria’s shares rose by more than 10% after it became the latest Canadian Licensed…
Read More...
Read More...
The 10 Largest Canadian Marijuana Stocks
With Canadian pot sales expected to hit $5 billion annually by 2024, it pays to know the biggest names in the industry. Though a lot of marijuana history has been made in recent years, most of it can be attributed to Canada, which became…
Read More...
Read More...
‘Incredible Launch Year’ For FDA-Approved CBD Medication
The numbers are in and the first FDA-backed medication using cannabidiol has surpassed even the most optimistic expectations, says GW Pharmaceuticals CEO Justin Gover. The British-based pharmaceutical company just announced their fourth…
Read More...
Read More...
CBD Warnings From FDA Spook Major Consumer Brands
The United States Food & Drug Administration has started 2020 as it ended 2019 – with a shot across the bows of the booming CBD industry. And, the FDA’s on-going irritation with the unregulated, low-THC cannabis market is…
Read More...
Read More...
Space Beckons For The Rocketing U.S. Hemp Industry
It’s safe to say the boom in U.S. hemp growing can now be described as being, literally ‘out of this world’. For the first time hemp cultures are being fired into space to see how they react to a zero-gravity environment.…
Read More...
Read More...